Crystallographic analysis of human hemoglobin elucidates the structural basis of the potent and dual antisickling activity of pyridyl derivatives of vanillin
Osheiza Abdulmalik(Children's Hospital of Philadelphia), Martin K. Safo(Virginia Commonwealth University), Jürgen Venitz(National Cancer Institute), Richmond Danso‐Danquah(Children's Hospital of Philadelphia), Qiukan Chen(Children's Hospital of Philadelphia), Mohini S. Ghatge(Children's Hospital of Philadelphia), Ijeoma Nnamani(Duke University), Donald J. Abraham(Virginia Commonwealth University), Dorothy N. Eseonu(Virginia Union University), Jisheng Yang(Children's Hospital of Philadelphia), Apurvasena Parikh(AbbVie (United States)), Toshio Asakura(Children's Hospital of Philadelphia), Faik N. Musayev(Virginia Commonwealth University)
Acta Crystallographica Section D Biological Crystallography
October 18, 2011
Cited by 53
Related Papers
In vivo hematopoietic stem cell modification by mRNA delivery
|Science|2023|321
Hemoglobin as a receptor of drugs and peptides: x-ray studies of the stereochemistry of binding
|Journal of the American Chemical Society|1986|301
2‐Methoxyestradiol, a Promising Anticancer Agent
|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2003|276
5‐hydroxymethyl‐2‐furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells<sup>†,‡</sup>
|British Journal of Haematology|2005|244